Successful efavirenz dose reduction guided by therapeutic drug monitoring.


Autoria(s): Fayet Mello A.; Buclin T.; Decosterd L.A.; Delhumeau C.; di Iulio J.; Fleurent A.; Schneider M.P.; Cavassini M.; Telenti A.; Hirschel B.; Calmy A.
Data(s)

2011

Identificador

http://serval.unil.ch/?id=serval:BIB_AC2598E4B289

isbn:2040-2058 (Electronic)

pmid:21447868

doi:10.3851/IMP1742

Idioma(s)

en

Fonte

Antiviral Therapy, vol. 16, no. 2, pp. 189-197

Palavras-Chave #Anti-HIV Agents/administration & dosage; Anti-HIV Agents/therapeutic use; Bayes Theorem; Benzoxazines/administration & dosage; Benzoxazines/therapeutic use; Drug Monitoring/methods; Female; HIV Infections/drug therapy; HIV Infections/virology; HIV-1/drug effects; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors/administration & dosage; Reverse Transcriptase Inhibitors/therapeutic use; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article